OBJECT: To assess the role of Topiramate in reducing migraine related disability and improvement
in quality of life in migraine sufferers comparing with conventionally used drug propranolol.
BACKGROUND: Epilepsy and migraine have some biological features in common; therefore antiepileptic
drugs are suppose to be effective in migraine prophylaxis beside active treatment, in
reducing migraine headache attacks and therefore can improve sufferers’ quality of life.
METHODS: Seventy diagnosed patients of migraine were enrolled in the study and 64 completed
the whole study period (12 weeks). They were divided in two groups: A (Topiramate) and
B (Propanolol). MIDAS scores were observed at day-0 and day-90 and results were statistically
RESULTS: Group received Topiramate showed better response and overall reduction was
Migraine, Prophylaxis, Topiramate, Propranolol, MIDAS(Migraine Disability Assessment)
Health technology assessment and economic evaluation: Is it applicable for the traditional medicine?
Integrative medicine research. 2022; 11(1): 100756
Chemometric analysis of the global pattern of volatile organic compounds in the exhaled breath of patients with COVID-19, post-COVID and healthy subjects. Proof of concept for post-COVID assessment.
Zamora-Mendoza BN, DĂaz de LeĂłn-MartĂnez L, RodrĂguez-Aguilar M, Mizaikoff B, Flores-RamĂrez R
Talanta. 2022; 236(): 122832
Rethinking the health implications of society-environment relationships in built areas: An assessment of the access to healthy and hazards index in the context of COVID-19.
Moore HE, Hill B, Siriwardena AN, Tanser F, Spaight R
Landscape and urban planning. 2022; 217(): 104265
Energy and environmental sustainability of waste personal protective equipment (PPE) treatment under COVID-19.
Zhao X, KlemeĹˇ JJ, Fengqi You
Renewable & sustainable energy reviews. 2022; 153(): 111786
In Vitro Assessment of Drug Activity Against Mycobacterium ulcerans.
Komm OD, Almeida DV, Converse PJ, Nuermberger EL
Methods in molecular biology (Clifton, N.J.). 2022; 2387(): 189-194